Concurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in inoperable Stage III NSCLC

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCalikusu, Z.
dc.contributor.authorUgurluer, G.
dc.contributor.authorSerin, M.
dc.contributor.authorSedef, A. M.
dc.contributor.authorMertsoylu, H.
dc.contributor.authorBesen, A.
dc.contributor.authorKose, F.
dc.date.accessioned2025-10-16T15:26:38Z
dc.date.issued2017
dc.identifier.doi10.1016/j.jtho.2017.09.1705
dc.identifier.otherWOS:000463860802302
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8416
dc.publisherELSEVIER SCIENCE INC
dc.sourceJOURNAL OF THORACIC ONCOLOGY
dc.subjectlung cancer
dc.subjectcarboplatin\\-paclitaxel
dc.subjectChemoradiotherapy
dc.titleConcurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in inoperable Stage III NSCLC
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS